Lakefront Biotherapeutics
No trades
No trades
Peers for comparison
10.53 USD
362.14 M USD
1.26 B USD
49.01 M
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Henry O. Gosebruch
Website
Headquarters
Mechelen
Founded
1999
IPO date
May 6, 2005
ISIN
US36315X1019
CUSIP
36315X101
FIGI
BBG000BJQY75
Identifiers
ISIN US36315X1019
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
